COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 1157: Articles 11561-11570  | Next

ChAdOx1 n-COV-19 Vaccine Side Effects Among Health Care Workers in Trinidad and Tobago
Gopaul, C. D., Ventour, D., Thomas, D.
10.1101/2021.11.09.21264627 — Posted: 2021-11-10
Minimal in-school SARS-CoV-2 transmission with strict mitigation protocols at two independent schools in Nashville, TN
Peetluk, L. S., Rebeiro, P. F., Edwards, K. M., Banerjee, R., Mallal, S. A., Aronoff, D. M., Lipworth, L., Katz, S. E.
10.1101/2021.11.09.21266140 — Posted: 2021-11-10
Transcriptome analysis of SARS-CoV-2 naive and recovered individuals vaccinated with inactivated vaccine
Zhang, Y., Guo, X., Li, C., Kou, Z., Lin, L., Yao, M., Pang, B., Zhang, X., Duan, Q., Tian, X., Xing, Y., Jiang, X.
10.1101/2021.11.05.467537 — Posted: 2021-11-10
A Flexible Data-Driven Framework for COVID-19 Case Forecasting Deployed in a Developing-world Public Health Setting
Jain, S., Tiwari, A., Bannur, N., Deva, A., Shingi, S., Shah, V., Kulkarni, M., Deka, N., Ramaswami, K., Khare, V., Maheshwari, H., Dhavala, S., Sreedharan, J., White, J., Merugu, S., Raval, A.
10.1101/2021.11.01.21260020 — Posted: 2021-11-10
Evidence for a long-r ange RNA-RNA interaction between ORF8 and the downstream region of the Spike polybasic insertion of SARS-CoV-2
Manzourolajdad, A., Pereira, F.
10.1101/2021.11.09.467911 — Posted: 2021-11-09
A self-amplifying mRNA COVID-19 vaccine drives potent and broad immune responses at low doses that protects non-human primates against SARS-CoV-2
Rappaport, A. R., Hong, S.-J., Scallan, C. D., Gitlin, L., Akoopie, A., Boucher, G. R., Egorova, M., Espinosa, J. A., Fidanza, M., Kachura, M. A., Shen, A., Sivko, G., Van Abbema, A., Veres, R. L., Jooss, K.
10.1101/2021.11.08.467773 — Posted: 2021-11-09
COVID-19: a study about the impact of coronavirus on physicians of La Plata, Argentina
Croce, M. V., Chiappa, E., Moiso, A., Rabassa, M. E.
10.1101/2021.11.05.21265969 — Posted: 2021-11-09
Modeling COVID-19 epidemic trends and health system needs leading to projections for developing countries: a case study of Thailand
Metchanun, N., Borgemeister, C., Bever, C., Galick, D.
10.1101/2021.11.05.21265992 — Posted: 2021-11-09
Waning, Boosting and a Path to Endemicity for SARS-CoV-2.
Keeling, M. J., Thomas, A. C., Hill, E. M., Thompson, R. N., Dyson, L. N., Tildesley, M., Moore, S.
10.1101/2021.11.05.21265977 — Posted: 2021-11-09
Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease
Davenport, B. J., Catala, A., Weston, S. M., Johnson, R. M., Ardunay, J., Hammond, H. L., Dillen, C., Frieman, M. B., Catalano, C. E., Morrison, T. E.
10.1101/2021.11.08.467648 — Posted: 2021-11-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).